Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Nov 28, 2024 5:55am
Buzz on the Bullboards: Stocks to watch in volatile times.
The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace.
read article.
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Nov 25, 2024 2:38pm
RE:RE:RE:RE:RE:RE:RE:Launch q1?
I've noticed you seem upset, my lovely crybaby. Is there anything I can do to help?
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Nov 25, 2024 2:30pm
RE:RE:RE:RE:RE:RE:Launch q1?
Funny guy
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Nov 25, 2024 2:27pm
RE:RE:RE:RE:RE:Launch q1?
Flurglehorn the magnificent! Zorp the Zorpalorp has declared a zizzlefritz! All hail the mighty snorfleblatz, and pass the jimjamalamadingdongs! Beware the grumblegroff, for he seeks the
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Nov 25, 2024 2:21pm
RE:RE:RE:RE:Launch q1?
If you trust howard you must be mentally limited:-)))
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Nov 25, 2024 2:19pm
RE:RE:RE:Launch q1?
Your question was about trust and I have answered that. Are you a bit confused or just mentally limited?
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Nov 25, 2024 2:15pm
RE:RE:Launch q1?
Why? Just a feeling :-)
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Nov 25, 2024 2:12pm
RE:Launch q1?
Yes, I do! (*^^)/*
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Nov 25, 2024 1:36pm
Launch q1?
Is there anybody who trust howard that we will see a product in q1?
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Nov 25, 2024 11:55am
RE:RE:New post on X
They have forgotten the most important factor in the comparison: Retinol is cheap
(2179)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 25, 2024 10:40am
RE:New post on X
Forgot one. Retinoids are usually applied at night because they make the skin hypersensitive to UV radiation.
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Nov 25, 2024 10:22am
RE:After the flurry of tweets
True
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Nov 25, 2024 10:21am
After the flurry of tweets
I actually thought they might have something to say in an actual news release. But, apparently, this is just more smoke and mirrors bs from this disgusting "management".
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Nov 22, 2024 7:33am
RE:New post on X
Just more rehashed old news. What concerns me is that they tend to put out these kinds of tweets when nothing material is going on. If we don't get that financial backer, we are going nowhere.
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Nov 22, 2024 3:55am
New post on X
https://drive.google.com/file/d/12_pQro1PUpHqHTXvmOIA9lHewIjAmFbZ/view
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Nov 21, 2024 7:45pm
RE:DAMMIT! WRONG AGAIN!
What will it take = Revenue. They need to start getting royalties and product sales before the market is going to give them any respect or chance of putting a dollar sign in front of
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >